Follow
Thomas Katairo
Thomas Katairo
Epidemiologist
Verified email at idrc-uganda.org
Title
Cited by
Cited by
Year
Changing antimalarial drug sensitivities in Uganda
SA Rasmussen, FG Ceja, MD Conrad, PK Tumwebaze, O Byaruhanga, ...
Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 01516-17, 2017
632017
Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study
PK Tumwebaze, T Katairo, M Okitwi, O Byaruhanga, S Orena, V Asua, ...
The Lancet Microbe 2 (9), e441-e449, 2021
382021
Evolution of partial resistance to artemisinins in malaria parasites in Uganda
MD Conrad, V Asua, S Garg, D Giesbrecht, K Niaré, S Smith, ...
New England Journal of Medicine 389 (8), 722-732, 2023
372023
Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda
PK Tumwebaze, MD Conrad, M Okitwi, S Orena, O Byaruhanga, T Katairo, ...
Nature communications 13 (1), 6353, 2022
352022
Interventions to increase youth employment: An evidence and gap map
R Apunyo, H White, C Otike, T Katairo, S Puerto, D Gardiner, ...
Campbell Systematic Reviews 18 (1), e1216, 2022
142022
Effect and implementation experience of intensive adherence counseling in a public HIV care center in Uganda: a mixed-methods study
Z Lukyamuzi, S Etajak, T Katairo, D Mukunya, M Tetui, A Ssenyonjo, ...
BMC infectious diseases 21, 1-15, 2021
92021
Household poverty, schooling, stigma and quality of life in adolescents with epilepsy in rural Uganda
R Anguzu, P Akun, T Katairo, C Abbo, A Ningwa, R Ogwang, AD Mwaka, ...
Epilepsy & Behavior 114, 107584, 2021
92021
Adherence to oral HIV pre-exposure prophylaxis among female sex workers in Kampala, Uganda
GK Nalukwago, JB Isunju, T Muwonge, T Katairo, N Bunani, F Semitala, ...
African Health Sciences 21 (3), 1048-1058, 2021
72021
Susceptibilities of Ugandan Plasmodium falciparum isolates to proteasome inhibitors
S Garg, O Kreutzfeld, S Chelebieva, PK Tumwebaze, O Byaruhanga, ...
Antimicrobial agents and chemotherapy 66 (10), e00817-22, 2022
62022
Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates
O Kreutzfeld, PK Tumwebaze, O Byaruhanga, T Katairo, M Okitwi, ...
The Journal of Infectious Diseases 225 (4), 696-704, 2022
62022
Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study. Lancet Microbe 2: e441-e449
PK Tumwebaze, T Katairo, M Okitwi, O Byaruhanga, S Orena, V Asua, ...
62021
Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda—An evaluation of the HIV test and treat strategy
A Katende, L Nakiyingi, I Andia-Biraro, T Katairo, R Muhumuza, ...
Plos one 17 (8), e0268122, 2022
42022
Role and utility of COVID-19 laboratory testing in low-income and middle-income countries: protocol for rapid evidence synthesis
OK Ouma, K Ephraim, N Loyce, E Namisango, F Nalugoda, R Ndagire, ...
BMJ open 11 (10), e050296, 2021
42021
Associations between varied susceptibilities to PfATP4 inhibitors and genotypes in Ugandan Plasmodium falciparum isolates
O Kreutzfeld, SA Rasmussen, AA Ramanathan, PK Tumwebaze, ...
Antimicrobial Agents and Chemotherapy 65 (10), 10.1128/aac. 00771-21, 2021
42021
PROTOCOL: Interventions to increase youth employment: An evidence and gap map
R Apunyo, H White, C Otike, T Katairo, S Puerto, D Gardiner, ...
Campbell Systematic Reviews 17 (4), e1196, 2021
32021
Blood culture testing outcomes among non-malarial febrile children at antimicrobial resistance surveillance sites in Uganda, 2017–2018
R Kisame, R Najjemba, J van Griensven, FE Kitutu, K Takarinda, ...
Tropical Medicine and Infectious Disease 6 (2), 71, 2021
32021
Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
P Orishaba, JN Kalyango, P Byakika-Kibwika, E Arinaitwe, B Wandera, ...
Plos one 15 (11), e0240838, 2020
32020
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline
O Kreutzfeld, PK Tumwebaze, M Okitwi, S Orena, O Byaruhanga, ...
Microbiology Spectrum 11 (3), e05236-22, 2023
22023
Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East Asia
CPG Meier-Scherling, OJ Watson, V Asua, I Ghinai, T Katairo, S Garg, ...
medRxiv, 2024.02. 03.24302209, 2024
2024
Role and Utility of COVID-19 Laboratory Testing in Low-and Middle-Income Countries: A Systematic Review of Diagnostic Test Accuracy Studies
KO Ojiambo, E Kisangala, L Nakalembe, E Namisango, F Nalugoda, ...
2023
The system can't perform the operation now. Try again later.
Articles 1–20